Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.

Cetin I, Carlson SE, Burden C, et al. Am J Obstet Gynecol MFM 2024; 6(2): 101251.

Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.

18 Feb 2025

This clinical practice guideline examines the role of omega-3 fatty acids, specifically docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), in reducing the risk of preterm and early preterm births.

Developed with support from multiple medical-scientific organisations, the guideline is based on a comprehensive review of strong evidence from randomised clinical trials and a formal consensus process. Key recommendations include:

The guideline emphasises that pregnant women with low DHA intake or blood levels are at an increased risk of preterm birth. For these women, a total daily intake of 600 to 1000 mg of DHA+EPA (or DHA alone) is recommended, starting preferably before 20 weeks' gestation and continuing until approximately 37 weeks or childbirth.

Identifying women with inadequate omega-3 intake can be achieved through standardised dietary assessments or blood measurements, though further standardisation of laboratory methods is needed. Providing information on achieving appropriate omega-3 intake is crucial for women and their partners.

Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.
Cetin I, Carlson SE, Burden C, et al. Am J Obstet Gynecol MFM 2024; 6(2): 101251.

https://pubmed.ncbi.nlm.nih.gov/38070679/

Spread the word
DHA EPA Omega-3 preterm birth Research William S Harris
Back to blog